Susie Shih Yin Huang

Susie Shih Yin Huang

Auto-generated profile, based on publicly available information

Susie Shih Yin Huang

Sidra Medicine , Doha

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
NHNicholas Hernandez
Nicholas Hernandez
IMIsabelle Melki
Isabelle Melki
HJHuie Jing
Huie Jing
THTanwir Habib
Tanwir Habib
SHSusie S.Y. Huang
Susie S.Y. Huang
JCJean-Laurent Casanova
Jean-Laurent Casanova
Life-threatening pulmonary influenza can be caused by inborn errors of type I and III IFN immunity. We report a 5-yr-old child with severe pulmonary influenza at 2 yr. She is homozygous for a loss-of-function IRF9 allele. Her cells activate gamma-activated factor (GAF) STAT1 homodimers but not IFN-stimulated gene factor 3 (ISGF3) trimers (STAT1/STAT2/IRF9) in response to IFN-α2b. The transcriptome induced by IFN-α2b in the patient’s cells is much narrower than that of control cells; however, induction of a subset of IFN-stimulated gene transcripts remains detectable. In vitro, the patient’s cells do not control three respiratory viruses, influenza A virus (IAV), parainfluenza virus (PIV), and respiratory syncytial virus (RSV). These phenotypes are rescued by wild-type IRF9, whereas silencing IRF9 expression in control cells increases viral replication. However, the child has controlled various common viruses in vivo, including respiratory viruses other than IAV. Our findings show that human IRF9- and ISGF3-dependent type I and III IFN responsive pathways are essential for controlling IAV.

1 November 2021 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MTMohammed Toufiq
Mohammed Toufiq
SHSusie Shih Yin Huang
Susie Shih Yin Huang
SBSabri Boughorbel
Sabri Boughorbel
MAMohamed Alfaki
Mohamed Alfaki
DRDarawan Rinchai
Darawan Rinchai
MGMathieu Garand
Mathieu Garand
Sepsis develops after a dysregulated host inflammatory response to a systemic infection. Identification of sepsis biomarkers has been challenging because of the multifactorial causes of disease susceptibility and progression. Public transcriptomic data are a valuable resource for mechanistic discoveries and cross-studies concordance of heterogeneous diseases. Nonetheless, the approach requires structured methodologies and effective visualization tools for meaningful data interpretation. Currently, no such database exists for sepsis or systemic inflammatory diseases in human. Hence we curated SysInflam HuDB (http://sepsis.gxbsidra.org/dm3/geneBrowser/list), a unique collection of human blood transcriptomic datasets associated with systemic inflammatory responses to sepsis. The transcriptome collection and the associated clinical metadata are integrated onto a user-friendly and Web-based interface that allows the simultaneous exploration, visualization, and interpretation of multiple datasets stemming from different study designs. To date, the collection encompasses 62 datasets and 5719 individual profiles. Concordance of gene expression changes with the associated literature was assessed, and additional analyses are presented to showcase database utility. Combined with custom data visualization at the group and individual levels, SysInflam HuDB facilitates the identification of specific human blood gene signatures in response to infection (e.g., patients with sepsis versus healthy control subjects) and the delineation of major genetic drivers associated with inflammation onset and progression under various conditions.

20 January 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
SHSusie S. Y. Huang
Susie S. Y. Huang
FAFatima Al Ali
Fatima Al Ali
SBSabri Boughorbel
Sabri Boughorbel
MTMohammed Toufiq
Mohammed Toufiq
DCDamien Chaussabel
Damien Chaussabel
MGMathieu Garand
Mathieu Garand
Prevalence of allergies has reached ~50% of industrialized populations and with children under ten being the most susceptible. However, the combination of the complexity of atopic allergy susceptibility/development and environmental factors has made identification of gene biomarkers challenging. The amount of publicly accessible transcriptomic data presents an unprecedented opportunity for mechanistic discoveries and validation of complex disease signatures across studies. However, this necessitates structured methodologies and visual tools for the interpretation of results. Here, we present a curated collection of transcriptomic datasets relevant to immunoglobin E (IgE)-mediated atopic diseases (ranging from allergies to primary immunodeficiencies). 30 datasets from the Gene Expression Omnibus (GEO), encompassing 1761 transcriptome profiles, were made available on the Gene Expression Browser (GXB), an online and open-source web application that allows for the query, visualization, and annotation of metadata. The thematic compositions, disease categories, sample number, and platforms of the collection are described. Ranked gene lists and sample grouping are used to facilitate data visualization/interpretation and are available online via GXB ( http://ige.gxbsidra.org/dm3/geneBrowser/list ). Dataset validation using associated publications showed good concordance in GXB gene expression trend and fold-change. Database URL: http://ige.gxbsidra.org/dm3/geneBrowser/list